australia peptide import seizure fine cjc-1295 ipamorelin 2024 2025 (No DAC) Research Buy CJC-1295 + Ipamorelin in

The DAC modification enables albumin binding, extending the half-life to 6-8 days

It is used as an anti-aging therapy and to treat obesity and other metabolic disorders

What Studies Have NOT Demonstrated in Humans Despite community claims, no controlled human trial has demonstrated: A specific body fat percentage reduction attributable to LR3 IGF-1 cycling A specific lean mass gain figure for the standard 10-day-on / 4-week-off pattern Cardiovascular safety endpoints across repeated cycles Long-term cancer-incidence data for cycled LR3 IGF-1 use Epidemiological data on chronically elevated endogenous IGF-1 has raised theoretical cancer concerns (Yoshida & Delafontaine, 2020), and that concern is one reason community protocols favor short, spaced cycles rather than continuous use

Neutralizes free radicals, reducing signs of aging

This is my go-to source now